In this comprehensive review, we explore the various cGAS signaling pathways, the role of cGAS dysregulation in inflammatory bowel disease (IBD) and GI malignancies, and the therapeutic interventions targeting these pathways. Here, CGAS is linked to inflammatory bowel disease.